VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
SBIR TOPIC 081: ADJUVANT DEVELOPMENT FOR VACCINES AGAINST INFECTIOUS OR IMMUNE-MEDIATED DISEASES Solicitation ID/Procurement Identifier: PHS20201 Ultimate Completion Date: Wed Aug 31 17:00:00 GMT 2022
of a Simian Immunodeficiency Virus (SIV) and Simian Human Immunodeficiency Virus (SHIV) DatabaseTopic 114 - Point-of-Care HIV Viral Load, Drug Resistance, and Adherence AssaysTopic 115 - Development of Diagnostics to Differentiate HIV Infection from Vaccine-Induced SeropositivityTopic 116 - Adjuvant Discovery for Vaccines for Infectious and Immune-Mediated DiseasesTopic 117 - Adjuvant Development for Vaccines for Infectious and Immune-Mediated DiseasesTopic
DEVELOPMENT OF SAPONIN DMLT ADJUVANT (SDA) Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
129 - Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian ModelsTopic 130 - Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune-Mediated DiseasesTopic 131 - Development of Bacteriophage for Treatment of Mycobacterial InfectionsTopic 132 - Novel Diagnostic Biomarker Discovery and Validation for Malaria and Select Neglected Tropical Diseases (NTDs)Topic 133 - Development of a Serological Test
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
